Dr Peters is not out , as of 1st January 2015 , a 2 year consulting agreement as well as continued vesting of equity awards going forward ,most of Peters good inventing work is done bar some consulting to refine and improve the device , its now up to the team at SSH to gain FDA approval , commercialize and market c-pulse 1 and 2 to address CHF class 3 and 4 plus explore other additional markets , seems a logical and economic progression for SSH .
- Forums
- ASX - By Stock
- Prospects for 2015
Dr Peters is not out , as of 1st January 2015 , a 2 year...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)